Alligator Energy (ASX:AGE) is an Australian, ASX-listed, exploration company focused on uranium and energy related minerals, principally cobalt-nickel. Alligator’s Directors have significant experience in the exploration, development and operations of both uranium and nickel projects (both laterites and sulphides).
Copyright 2024 – Finance News Network
16 Nov 2023 - Linius Technologies Limited (ASX:LNU) CEO and Executive Director James Brennan discusses the company's quarterly performance and its technology for rendering video files as flexible as other forms of data.
18 May 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's pipeline and discusses the recent licensing of an asset from UCLA.
28 May 2021 - Beston Global Foods Limited (ASX:BFC) CFO and Acting CEO Darren Flew discusses the company's FY21 results, guidance and strategy, and provides an update on the company's lactoferrin expansion project at its Jervois dairy in South Australia.
15 Aug 2024 - Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.
04 Oct 2022 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY22 highlights, revenue drivers, growth investments, hybrid working tailwinds and the outlook for FY23.
16 June 2020 - Social Tree Global co-founders, Max Hannah and James Saward-Anderson share their top 5 hacks for harnessing the power of social media in financial services.
31 May 2023 - Ron Mitchell, Managing Director of Global Lithium Resources Limited (ASX:GL1), which owns two of the 14 lithium resources in Australia, discusses the price of lithium and progress on the company's projects.
23 Nov 2022 - Altech Chemicals Limited (ASX:ATC) CFO Martin Stein discusses the recent joint venture with Fraunhofer IKTS and the CERENERGY solid state sodium alumina battery.
27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and the company's recent FDA approval.